Semaglutide, while effective, has a higher risk profile including nausea, vomiting, pancreatitis, and a black box warning for thyroid tumors
Novo Nordisks recent data shows that the company is able to keep up with supply and demand requirements
GLP-1 therapies can benefit all of these factors, helping with weight loss, improving blood sugar control, lowering blood pressure, improving cholesterol profiles and reducing inflammation all at the same time
* No published clinical trials exist to confirm the safety or effectiveness of the product
Coverage may depend on BMI, weight-related conditions and whether the plan includes anti-obesity medications